Aurobindo Pharma plans to acquire a 26% stake in Swarnaakshu Solar Power to secure renewable energy for its operations. This investment aims to develop a solar project for internal electricity use, enhancing cost efficiency and sustainability. The deal aligns with India’s regulations for captive power generation and emphasizes the industry's shift toward renewable solutions.

The post Aurobindo Pharma to Acquire 26% Stake in Swarnaakshu Solar Power for Captive Renewable Energy Project appeared first on SolarQuarter.